Next Article in Journal
Black Box Warning by the United States Food and Drug Administration: The Impact on the Dispensing Rate of Benzodiazepines
Previous Article in Journal
The Comparative Safety and Efficacy of Resmetirom and Semaglutide in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Systematic Review
 
 
Review

Article Versions Notes

Pharmacoepidemiology 2025, 4(3), 15; https://doi.org/10.3390/pharma4030015
Action Date Notes Link
article pdf uploaded. 9 July 2025 14:57 CEST Version of Record https://www.mdpi.com/2813-0618/4/3/15/pdf-vor
article xml file uploaded 10 July 2025 09:50 CEST Original file -
article xml uploaded. 10 July 2025 09:50 CEST Update https://www.mdpi.com/2813-0618/4/3/15/xml
article pdf uploaded. 10 July 2025 09:50 CEST Updated version of record https://www.mdpi.com/2813-0618/4/3/15/pdf
article html file updated 10 July 2025 09:54 CEST Original file -
article html file updated 28 August 2025 08:45 CEST Update -
article html file updated 15 September 2025 08:11 CEST Update https://www.mdpi.com/2813-0618/4/3/15/html
Back to TopTop